Merck Silence On OTC Singulair Speaks Volumes On Switch Outlook

Merck’s silence on an OTC version of Singulair is a sign of the relatively “quiet” 2015 switch market despite the call for novel switches, particularly to treat chronic conditions, from FDA’s Nonprescription Drug Safe Use Regulatory Expansion Initiative.

Merck & Co. Inc.’s silence on its proposed Rx-to-OTC Singulair switch since an FDA advisory panel recommended against approval could give multiple signals for that product in particular as well as the switch market in general.

Despite the call for novel switches, particularly to treat chronic conditions, from FDA’s Nonprescription Drug Safe Use Regulatory Expansion Initiative,...

More from Rx-to-OTC Switch

Haleon Study: Self-Care Policies Could Save Finland €60m Per Year

 
• By 

Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.

PAGB: UK Gov Must Invest In Self-Care To Realize ‘Untapped Potential’

 
• By 

Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By 

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

AESGP Annual Meeting: Commission Must ‘Think Carefully’ Before Reverse-Switching Antimicrobials

 
• By 

If the European Commission is serious about improving the competitiveness of the European Union, it should ditch the idea of making commonly used OTC antimicrobials like thrush treatments and cold sore creams prescription-only, warns Greek Medicines Agency president Evangelos Manolopoulos

More from Health

Opella Claims Sustainability Leadership Position With Global B Corp Certification

 
• By 

Cutting greenhouse gas emissions and obtaining its electricity from renewable sources has helped Opella earn global B Corp certification.

Stada CEO Has ‘Big Hopes’ For AI-Driven Personalized Healthcare

 
• By 

“Harnessing AI’s astounding abilities to improve people’s lives and relieve overburdened healthcare systems is one of the great opportunities of our time,” argues Stada CEO Peter Goldschmidt in the company's Health Report 2025.

People On The Move: Appointments At Haleon, Nestlé, Cornerstone

 
• By 

A round up of the latest European health & wellness moves: Haleon names Lauder's Haney as R&D chief; Nestle nominates Isla for board chair; Cornerstone appoints Stada's Ed Round.